a pharmaceutical composition comprising a modified amino acid sequence of the human immunodeficiency virus (hiv) transcriptional activating protein (tat) and use of a tat-derived polypeptide to treat cancer

摘要

Pharmaceutical composition comprising a modified amino acid sequence of the human immunodeficiency virus (hiv) transcriptional activating protein (tat) and use of a tat-derived polypeptide to treat cancer are disclosed herein. Methods of treating cancer by administering a trans-polypeptide modified human immunodeficiency virus (hiv) transcriptional activator (tat) with enhanced immunostimulatory properties over unmodified tat polypeptide.